文献速递传染病防控与疫情报告免疫规划

阿根廷选定地区被动流行病学监测系统估计的预期登革热血清流行率:评估登革热疫苗适用性的替代指标

Estimation of expected dengue seroprevalence from passive epidemiological surveillance systems in selected areas of Argentina: A proxy to evaluate the applicability of dengue vaccination.
PubMed 文献 · Vaccine · 2018-01-11

本研究采用马尔可夫模型,基于被动流行病学监测系统数据模拟0至9岁儿童队列,估计阿根廷米西奥内斯省、萨尔塔省和布宜诺斯艾利斯市9岁儿童的预期登革热血清流行率。结果显示米西奥内斯省为79%(95%CI:46-100%),萨尔塔省为22%(95%CI:14-30%),布宜诺斯艾利斯市为7%(95%CI:3-11%)。模型可用于缺乏血清流行率数据的地区,米西奥内斯省在广泛情景下预期血清流行率高于70%,应分析针对9岁以上血清阳性儿童的疫苗接种策略。

要点

  • 米西奥内斯省9岁儿童预期登革热血清流行率为79%(95%CI:46-100%)。
  • 萨尔塔省9岁儿童预期血清流行率为22%(95%CI:14-30%)。
  • 布宜诺斯艾利斯市9岁儿童预期血清流行率为7%(95%CI:3-11%)。

核心结论

  • 该模型可在缺乏登革热血清流行率信息的地区进行估计。
  • 米西奥内斯省在广泛情景下预期血清流行率高于70%,应分析针对9岁以上血清阳性儿童的疫苗接种策略,包括安全性、成本效果和预算影响等进一步考虑。

研究设计与样本

  • 使用马尔可夫模型,模拟0至9岁个体队列,以9岁时的免疫人群比例作为预期血清流行率的替代指标。
  • 模型参数包括报告的年登革热发病率、不明感染病例比例以及门诊和住院病例的扩张因子,作为转移概率。
  • 模型用于评估米西奥内斯省、萨尔塔省和布宜诺斯艾利斯市三个气候适宜性不同的地区。

主要发现

  • 米西奥内斯省9岁儿童组预期血清流行率为79%(95%CI:46-100%)。
  • 萨尔塔省9岁儿童组预期血清流行率为22%(95%CI:14-30%)。
  • 布宜诺斯艾利斯市9岁儿童组预期血清流行率为7%(95%CI:3-11%)。
  • 确定性敏感性分析显示,对结果影响最大的参数是不明感染病例的概率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current recommendations about dengue vaccination by the World Health Organization depend on seroprevalence levels and serological status in populations and individuals. However, seroprevalence estimation may be difficult due to a diversity of factors. Thus, estimation through models using data from epidemiological surveillance systems could be an alternative procedure to achieve this goal. OBJECTIVE: To estimate the expected dengue seroprevalence in children of selected areas in Argentina, using a simple model based on data from passive epidemiological surveillance systems. METHODS: A Markov model using a simulated cohort of individuals from age 0 to 9 years was developed. Parameters regarding the reported annual incidence of dengue, proportion of inapparent cases, and expansion factors for outpatient and hospitalized cases were considered as transition probabilities. The proportion of immune population at 9 years of age was taken as a proxy of the expected seroprevalence, considering this age as targeted for vaccination. The model was used to evaluate the expected seroprevalence in Misiones and Salta provinces and in Buenos Aires city, three settings showing different climatic favorability for dengue. RESULTS: The estimates of the seroprevalence for the group of 9-year-old children for Misiones was 79% (95%CI:46-100%), and for Salta 22% (95%CI:14-30%), both located in northeastern and northwestern Argentina, respectively. Buenos Aires city, from central Argentina, showed a likely seroprevalence of 7% (95%CI: 3-11%). According to the deterministic sensitivity analyses, the parameter showing the highest influence on these results was the probability of inapparent cases. CONCLUSIONS: This model allowed the estimation of dengue seroprevalence in settings where this information is not available. Particularly for Misiones, the expected seroprevalence was higher than 70% in a wide range of scenarios, thus in this province a vaccination strategy directed to seropositive children of >9 years should be analyzed, including further considerations as safety, cost-effectiveness, and budget impact.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Orellano P, Vezzani D, Quaranta N, et al. Estimation of expected dengue seroprevalence from passive epidemiological surveillance systems in selected areas of Argentina: A proxy to evaluate the applicability of dengue vaccination. Vaccine. 2018. PMID: 29331246. doi:10.1016/j.vaccine.2018.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。